Peter Greven Fett-Chemie GmbH & Co.KG Company Profile

06:01 EST 13th December 2018 | BioPortfolio

compnay 80 years after its foundation the Peter Greven Fett-Chemie GmbH & Co. KG company is a modern, future-orientated chemical works. From modest, but therefore enthousiastic beginnings the current state has been achieved by hard work, solid management and a product-related imaginativeness.The understanding for the problems of our customers and the ability to be able to help at solving them with experience and know-how, constitute the maxim of the Peter Greven company.


Peter-Greven-Straße 20-30
Bad Münstereifel


Phone: 49 (2253) 313-0
Fax: 49 (2253) 313-134

News Articles [497 Associated News Articles listed on BioPortfolio]

Global Metallic Stearates Market Status and Outlook 20182025 [Report Updated: 02082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

Tonnes of regulatory grief solved by the experts at SWC

Süd-West-Chemie GmbH (SWC), which provides thermosetting resins to the pharma industry, has developed two new product lines which can be used as substitutes for both formaldehyde and nonylphenol, mea...

Peter Huber Obituary

The family and employees of Peter Huber Kältemaschinenbau AG mourn the loss of their founder, long-standing CEO and Chairman of the Supervisory Board Peter Huber. The company founder died on June...

Making the Invisible Visible: Rapid Surface Testing for Corrosion Risks

ArticleKorroPads offer a cost-effective, non-destructive, and rapid alternative to traditional methods when it comes to the testing of material surfaces.

New financing round at oncgnostics GmbH close

The life sciences company oncgnostics GmbH was able to double its investment of 750,000 euros following the very rapid and successful completion of its second crowd investing campaign on Seedmatch. A...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

The Hon Peter Beattie, MP: Alliances and Objectives for Australian Trade

In this episode of PharmaTelevision News Review, Paul Larsmon talks with The Hon Peter Beattie, former Premier of Queensland, The Hon Peter Beattie, who is Queensland Trade Commissioner for North and ...

Peter Hoare

bmj;362/jul10_6/k2995/FAF1faThe youngest of three children to James and Ann Hoare, Peter Hoare was born in Liverpool. After distinguishing himself at St Mary’s College, Crosby, he was accepted to......

PubMed Articles [229 Associated PubMed Articles listed on BioPortfolio]

A tribute to professor Jonathan C Peter.

Emeritus Professor Jonathan Clemence Peter passed away in Wynberg, Cape Town, on April 02, 2018, after an illness confronted with quiet courage and dignity. A beloved father, husband, neurosurgeon, le...

Rejoinder to Mr. Peter J. Laud.

Peter M. Milner, 1919–2018

Towards new frontiers in neuroendocrinology: A tribute to Peter H. Seeburg.

XLIIIrd Sir Peter Freyer Memorial Lecture and Surgical Symposium.

Clinical Trials [61 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

CUstodiol Versus RInger: whaT Is the Best Agent?

Postoperative renal failure is the most significant risk factor for early mortality after elective surgical repair of thoracoabdominal aortic aneurysms (TAAAs). To prevent damages related...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

ED Overcrowding Validation Study

The aim of this study is to externally validate a new emergency department overcrowding estimation tool (SONET) developed at John Peter Smith Health Network (JPS).

Companies [630 Associated Companies listed on BioPortfolio]

Peter Greven Fett-Chemie GmbH & Co.KG

compnay 80 years after its foundation the Peter Greven Fett-Chemie GmbH & Co. KG company is a modern, future-orientated chemical works. From modest, but therefore enthousiastic beginnings the current ...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

CU Chemie Uetikon GmbH

CU Chemie Uetikon GmbH is located in Lahr, Germany, a picturesque old town with appr. 45.000 inhabitants at the border of the well-known Black Forest. We are active in research and development, proces...

NIGU Chemie GmbH

Nigu Chemie GmbH is the competence center for nitroguanidine and ultrapure guanidine salts in the business unit Fine Chemicals of the new Degussa AG. We are manufacturing and developing from laborator...


Loba Chemie was a venture started over 25 years ago to deal in Biochemicals and Reagents for life science research and other specialty chemicals. Loba Chemie today is one of the forerunners in the Ind...

More Information about "Peter Greven Fett-Chemie GmbH & Co.KG" on BioPortfolio

We have published hundreds of Peter Greven Fett-Chemie GmbH & Co.KG news stories on BioPortfolio along with dozens of Peter Greven Fett-Chemie GmbH & Co.KG Clinical Trials and PubMed Articles about Peter Greven Fett-Chemie GmbH & Co.KG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Peter Greven Fett-Chemie GmbH & Co.KG Companies in our database. You can also find out about relevant Peter Greven Fett-Chemie GmbH & Co.KG Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record